In line with this, we found that LINC00326 was downregulated in stage III and IV NSCLC tissues compared to stages I and II, suggesting that LINC00326 might be involved in NSCLC malignancy (Fig. 1c). This evidence concerns the gene LINC00326 and non-small cell lung carcinoma.